Glioma Diagnosis and Treatment
Moving in Neuro-Oncology, bioRxiv, Journal of Clinical Oncology, Oncogene, Acta Neuropathologica, Cell Reports, Clinical Cancer Research and medRxiv.
- Moved, week to 18 Nov 2026
- 0
- Papers in 60 days
- 186
Rebuilt
Moved this week
Nothing in this topic has moved yet this week.
Latest in Glioma Diagnosis and Treatment
Newest first · last 60 days
AI summary · may contain errors
NOEMTR difference mapping with Gd-DOTA in a rat infiltrative glioblastoma model (n = 5) delineates tumor core and infiltrative boundaries, with ~43% core signal reduction (p=0.003).
- Open access
- 2 cites
AI summary · may contain errors
Multimodal composite scoring detected ctDNA in 70% of CSF versus 17% of plasma samples from 28 pediatric CNS tumor patients, outperforming any single modality alone.
- Open access
AI summary · may contain errors
mRNA-LNP vaccination in an immunocompetent EGFRvIII-driven syngeneic glioblastoma model induces durable EGFRvIII-specific immunity, achieving complete tumor eradication and long-term protection after intracranial rechallenge.
- Open access
AI summary · may contain errors
A constrained rare-subregion correction within NETC improved pediatric BraTS-PEDs 2026 Task 2 cystic component segmentation Dice from 0.223 to 0.253 while preserving tumor-core and whole-tumor scores exactly.
- Open access
AI summary · may contain errors
Galectin-1–high glioblastoma cells isolated from patient-derived in vitro tumor–brain interface models preferentially migrate across stiffness interfaces, with invasion rate positively correlated to galectin-1 expression.
- Open access
AI summary · may contain errors
MGMT promoter methylation predicts progression-free and overall survival in glioblastoma treated with temozolomide, with hazard ratios of 2.07 and 2.13 using methylation-specific PCR and pyrosequencing.
AI summary · may contain errors
In 90 glioblastoma patients with RANO 2.0–confirmed progression, longitudinal FET PET showed significant increases at progression, with MTV expanding by +182%.
AI summary · may contain errors
Vorasidenib produced progressive MRI tumor shrinkage in 54 grade 2 IDH1/2-mutant astrocytomas and oligodendrogliomas, with median volume reductions reaching -55.5% by cycle 18.
AI summary · may contain errors
AlphaFold3-based modeling of the three human GLI-SUFU complexes reveals newly recognized contact interfaces, and binding assays confirm that many interface residues mutated in medulloblastoma and Gorlin syndrome are binding-defective.
- Open access
- 1 cites
AI summary · may contain errors
IL-8 produced by adult glioblastoma tumor cells instructs monocyte-derived macrophages to suppress healthy T cells, and neutralizing IL-8 restores T cell proliferation.
- Open access
AI summary · may contain errors
In a randomized phase III trial in 204 surgically treated patients with newly diagnosed brain metastases, R + TBRT markedly prolonged surgical bed recurrence outcomes versus R + SRT (HR 0.06 for time-to-SBR).
- Open access
- 3 cites
AI summary · may contain errors
B3GNT9 is significantly upregulated in glioblastoma tumor cells in the peritumoral brain zone (PBZ), and its high expression is linked to poor prognosis.
AI summary · may contain errors
KCa2.3 is identified as the only Ca2+-activated K+ channel compatible with executing pacemaker function in glioblastoma, and its inhibition reduces pacemaker Ca2+ activity.
- Open access
AI summary · may contain errors
Infratentorial ependymal tumors matching subependymoma DNA methylation profiles show two subtypes, including one with loss of chromosome 6 and TERT promoter mutations linked to shorter progression-free survival (p = 0.00014).
AI summary · may contain errors
In a histopathology-validated cohort of 61 IDH-wildtype glioblastoma patients (472 tissue samples), [18F]FET PET detects non-contrast-enhancing tumor tissue far better than CE-MRI (91.2% vs 52.6% sensitivity).
- Open access
AI summary · may contain errors
High-grade gliomas are highly aggressive brain tumors, and synapse-like neuron–glioma contacts are linked to neuronal activity that promotes tumor growth.
AI summary · may contain errors
MYT1L is identified as the dominant safeguard repressor that maintains the neuronal-like low-plasticity state in primary glioblastomas, restricting plasticity even under standard-of-care therapy.
- Open access
- 12 cites
AI summary · may contain errors
Spatially patterned transitions in human glioblastoma drive heterogeneity, moving cancer cells from developmental-like states toward glial injury response and hypoxia across 12 tumours.
- Open access
- 8 cites
AI summary · may contain errors
Dinutuximab plus sargramostim with COG induction cycles 3–5 was feasible and tolerable in 40 newly diagnosed high-risk neuroblastoma patients, with 92.0%–101.8% of planned DIN doses delivered.
- Open access
AI summary · may contain errors
Pretherapeutic tumor growth velocity (TGV) measured from serial preoperative MRI independently predicts shorter overall survival in 569 adults with grade 2–3 IDH-mutant lower-grade gliomas, with HR 1.046 per 1-mm/year.
AI summary · may contain errors
Within-patient resistant glioblastoma stem-like cell families show that TMZ selection yields mismatch repair-dependent stable resistance or drug tolerance, while IR selection increases radioresistance.
- Open access
AI summary · may contain errors
Diffuse gliomas integrate into neural circuits and drive bidirectional interactions that alter cortical excitation–inhibition balance and language network function, with dysfunction shaped by tumor and network factors.
- Open access
AI summary · may contain errors
Stress- and hypoxia-associated dedifferentiation programs are selectively enriched in paediatric B choroid plexus tumours and correlate with poorer survival.
- Open access
AI summary · may contain errors
A handheld fluorescence-spectroscopy plus diffuse reflectance probe in 33 glioma patients discriminated tumor from non-tumor with 85.82% sensitivity and 0.81 AUROC across 212 biopsy-matched sites.
Browse JClub
Journals this month
- bioRxiv6440
- medRxiv1747
- PNAS583
- JAMA366
- Sci Adv330
- Cell Rep320
- Environ Res218
- BMJ208
- EHJ206
- NAR176
- Plant Cell Environ173
- Nat Commun166
- Science152
- Environ Pollution151
- NEJM148
- New Phytol147
- Nature127
- Lancet127
Topics moving, week to 18 Nov 2026
- Gut microbiota and health9
- Single-cell and spatial transcriptomics6
- CAR-T cell therapy research4
- Global Cancer Incidence and Screening3
- Lung Cancer Treatments and Mutations3
- Pancreatic and Hepatic Oncology Research3
- Antibiotic Resistance in Bacteria3
- Bacteriophages and microbial interactions3
- Diabetes Management and Education3
- Immune cells in cancer3
By field
- General Science & Medicine22
- Clinical Medicine25
- Cardiology & Vascular Biology12
- Endocrinology & Metabolism10
- Gastroenterology & Hepatology7
- Public & Global Health4
- Cell & Molecular Biology30
- Immunology & Inflammation14
- Neuroscience14
- Psychiatry & Mental Health8
- Genomics & Bioinformatics29
- Pharmacology & Drug Discovery5
- Microbiology & Mycology34
- Oncology22
- Ecology & Evolution5
- Protected Cropping & Horticultural Science5
- Plant Physiology & Photobiology19
- Student Research1
